{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:58:10Z","timestamp":1778767090692,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003091","name":"Government of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.canlet.2019.11.022","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T20:12:37Z","timestamp":1574453557000},"page":"181-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Somatic gene mutation signatures predict cancer type and prognosis in multiple cancers with pan-cancer 1000 gene panel"],"prefix":"10.1016","volume":"470","author":[{"given":"Hai-Long","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng-Fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Hua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Long","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Hui","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zan-Mei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cai-Juan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Na","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2019.11.022_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.canlet.2016.09.001","article-title":"A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets","volume":"382","author":"Jia","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.11.022_bib2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.celrep.2018.06.025","article-title":"A pan-cancer compendium of genes deregulated by somatic genomic rearrangement across more than 1,400 cases","volume":"24","author":"Zhang","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2019.11.022_bib3","doi-asserted-by":"crossref","first-page":"7624","DOI":"10.1158\/1078-0432.CCR-08-1547","article-title":"Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development","volume":"14","author":"Sahin","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2019.11.022_bib4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2019.11.022_bib5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/bmj.38327.648472.82","article-title":"Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study","volume":"330","author":"Vineis","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.canlet.2019.11.022_bib6","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1001\/jamaoncol.2016.0740","article-title":"Association of physical activity by type and intensity with digestive system cancer risk","volume":"2","author":"Keum","year":"2016","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canlet.2019.11.022_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12398","article-title":"Long non-coding RNA PVT1: emerging biomarker in digestive system cancer","author":"Zhou","year":"2017","journal-title":"Cell Prolif"},{"key":"10.1016\/j.canlet.2019.11.022_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.dnarep.2018.08.003","article-title":"Mutational spectra and mutational signatures: insights into cancer aetiology and mechanisms of DNA damage and repair","volume":"71","author":"Phillips","year":"2018","journal-title":"DNA Repair"},{"key":"10.1016\/j.canlet.2019.11.022_bib9","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1111\/cas.14087","article-title":"Mutational burden and signatures in 4000 Japanese cancers provide insights into tumorigenesis and response to therapy","volume":"110","author":"Hatakeyama","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2019.11.022_bib10","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.1038\/ncomms5852","article-title":"Corrigendum: a pan-cancer proteomic perspective on the cancer genome atlas","volume":"6","author":"Akbani","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2019.11.022_bib11","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/dvdy.24485","article-title":"Pan-cancer survey of epithelial-mesenchymal transition markers across the Cancer Genome Atlas","volume":"247","author":"Gibbons","year":"2018","journal-title":"Dev. Dynam."},{"key":"10.1016\/j.canlet.2019.11.022_bib12","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/path.5028","article-title":"Pan-cancer insights from the Cancer Genome Atlas: the pathologist's perspective","volume":"244","author":"Lad","year":"2018","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2019.11.022_bib13","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.canlet.2012.11.002","article-title":"Whole-exome sequencing reveals recurrent somatic mutation networks in cancer","volume":"2","author":"Liu","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.11.022_bib14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.canlet.2017.09.014","article-title":"Major challenges related to tumor biological characteristics in accurate mutation detection of colorectal cancer by next-generation sequencing","volume":"410","author":"Li","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.11.022_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2018.03.005","article-title":"Primary and acquired EGFR T790M-mutant NSCLC patients identified by routine mutation testing show different characteristics but may both respond to osimertinib treatment","volume":"423","author":"Li","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.11.022_bib16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canlet.2017.07.013","article-title":"Clonal composition of human ovarian cancer based on copy number analysis reveals a reciprocal relation with oncogenic mutation status","volume":"405","author":"Sakai","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.11.022_bib17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome Med."},{"key":"10.1016\/j.canlet.2019.11.022_bib18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.canlet.2017.09.014","article-title":"Major challenges related to tumor biological characteristics in accurate mutation detection of colorectal cancer by next-generation sequencing","volume":"410","author":"Li","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.11.022_bib19","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1158\/1535-7163.MCT-17-0386","article-title":"Tumor mutational burden as an independent predictor of response to immunotherapy in diverse cancers","volume":"16","author":"Goodman","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2019.11.022_bib20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.canlet.2019.07.010","article-title":"The tumour microenvironment as an integrated framework to understand cancer biology","volume":"461","author":"Burgos-Panadero","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.11.022_bib21","first-page":"1091","article-title":"Phosphorus metabolism in cancer","volume":"16","author":"Papaloucas","year":"1960","journal-title":"Acta Unio Int. Contra Cancrum"},{"key":"10.1016\/j.canlet.2019.11.022_bib22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ijc.2910390222","article-title":"Growth of a human colonic adenocarcinoma cell line (HT 29) on microcarrier beads: metabolic studies by 31 phosphorus nuclear magnetic resonance spectroscopy","volume":"39","author":"Baetselier","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2019.11.022_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.canlet.2019.07.015","article-title":"YAP1-mediated pancreatic stellate cell activation inhibits pancreatic cancer cell proliferation","volume":"462","author":"Xiao","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.11.022_bib24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12272-016-0880-z","article-title":"RSK2 and its binding partners in cell proliferation, transformation and cancer development","volume":"40","author":"Cho","year":"2017","journal-title":"Arch Pharm. Res."},{"key":"10.1016\/j.canlet.2019.11.022_bib25","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1158\/0008-5472.CAN-04-0327","article-title":"IRSp53\/Eps8 complex is important for positive regulation of rac and cancer cell motility\/invasiveness","volume":"64","author":"Funato","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.11.022_bib26","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1200\/JCO.2017.76.8770","article-title":"Tumor mutation burden: leading immunotherapy to the era of precision medicine?","volume":"36","author":"Steuer","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2019.11.022_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mehy.2018.05.005","article-title":"Tumor mutation burden to tumor burden ratio and prediction of clinical benefit of anti-PD-1\/PD-L1 immunotherapy, Med","volume":"116","author":"Qin","year":"2018","journal-title":"Hypotheses"},{"key":"10.1016\/j.canlet.2019.11.022_bib28","doi-asserted-by":"crossref","first-page":"22338","DOI":"10.1038\/srep22338","article-title":"A targeted next-generation sequencing method for identifying clinically relevant mutation profiles in lung adenocarcinoma","volume":"6","author":"Shao","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2019.11.022_bib29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejca.2016.01.003","article-title":"Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation","volume":"57","author":"Tinhofer","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2019.11.022_bib30","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jmedgenet-2017-104811","article-title":"Clinical genetic testing using a custom-designed steroid-resistant nephrotic syndrome gene panel: analysis and recommendations","volume":"54","author":"Sen","year":"2017","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.canlet.2019.11.022_bib31","doi-asserted-by":"crossref","first-page":"47064","DOI":"10.18632\/oncotarget.16791","article-title":"Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer","volume":"8","author":"Tedaldi","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2019.11.022_bib32","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/bpa.12367","article-title":"Molecular diagnostics of gliomas using next generation sequencing of a glioma-tailored gene panel","volume":"27","author":"Zacher","year":"2017","journal-title":"Brain Pathol."},{"key":"10.1016\/j.canlet.2019.11.022_bib33","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s11684-017-0526-7","article-title":"Application of liquid biopsy in precision medicine: opportunities and challenges","volume":"11","author":"Wang","year":"2017","journal-title":"Front. Med."},{"key":"10.1016\/j.canlet.2019.11.022_bib34","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrclinonc.2017.14","article-title":"Integrating liquid biopsies into the management of cancer","volume":"14","author":"Siravegna","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2019.11.022_bib35","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.canlet.2018.09.012","article-title":"Application of liquid biopsy in bone and soft tissue sarcomas: present and future","volume":"439","author":"Li","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.11.022_bib36","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2014.222679","article-title":"Circulating tumor DNA as a liquid biopsy for cancer","volume":"61","author":"Heitzer","year":"2015","journal-title":"Clin. Chem."},{"key":"10.1016\/j.canlet.2019.11.022_bib37","doi-asserted-by":"crossref","first-page":"48832","DOI":"10.18632\/oncotarget.9453","article-title":"Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer","volume":"7","author":"Cheng","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2019.11.022_bib38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.canlet.2017.06.030","article-title":"Circulating tumour DNA (ctDNA) as a liquid biopsy for melanoma","volume":"404","author":"Calapre","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.11.022_bib39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13048-017-0369-5","article-title":"Circulating cell-free DNA and circulating tumor cells, the \"liquid biopsies\" in ovarian cancer","volume":"10","author":"Cheng","year":"2017","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.canlet.2019.11.022_bib40","doi-asserted-by":"crossref","first-page":"33614","DOI":"10.18632\/oncotarget.16833","article-title":"Correlation of genomic alterations assessed by next-generation sequencing (NGS) of tumor tissue DNA and circulating tumor DNA (ctDNA) in metastatic renal cell carcinoma (mRCC): potential clinical implications","volume":"8","author":"Hahn","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2019.11.022_bib41","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1158\/1078-0432.CCR-17-1439","article-title":"Hypermutated circulating tumor DNA: correlation with response to checkpoint inhibitor-based immunotherapy","volume":"23","author":"Khagi","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2019.11.022_bib42","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1096\/fj.14-264580","article-title":"Pulmonary expression of CYP2A13 and ABCB1 is regulated by FOXA2, and their genetic interaction is associated with lung cancer","volume":"29","author":"Xiang","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.canlet.2019.11.022_bib43","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1158\/1055-9965.EPI-14-1380-T","article-title":"Functional variants in notch pathway genes NCOR2, NCSTN, and MAML2 predict survival of patients with cutaneous melanoma","volume":"24","author":"Zhang","year":"2015","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.canlet.2019.11.022_bib44","doi-asserted-by":"crossref","first-page":"2869572","DOI":"10.1155\/2016\/2869572","article-title":"Synergistic effects of vascular endothelial growth factor on bone morphogenetic proteins induced bone formation in vivo: influencing factors and future research directions","volume":"2016","author":"Li","year":"2016","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.canlet.2019.11.022_bib45","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.canlet.2017.10.011","article-title":"Genomic predictors of chemotherapy efficacy in advanced or recurrent gastric cancer in the GC0301\/TOP002 phase III clinical trial","volume":"412","author":"Das","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.11.022_bib46","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.canlet.2016.02.016","article-title":"Mucins and associated glycan signatures in colon adenoma-carcinoma sequence: prospective pathological implication(s) for early diagnosis of colon cancer","volume":"374","author":"Krishn","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.11.022_bib47","doi-asserted-by":"crossref","first-page":"8857","DOI":"10.1038\/s41598-018-27214-6","article-title":"Cancer drug response profile scan (CDRscan): a deep learning model that predicts drug effectiveness from cancer genomic signature","volume":"8","author":"Yoosup","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2019.11.022_bib48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00428-019-02576-y","article-title":"Mutation in BRAF and SMAD4 associated with resistance to neoadjuvant chemoradiation therapy in locally advanced rectal cancer","volume":"475","author":"Jiang","year":"2019","journal-title":"Virchows Arch."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519305774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519305774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:46:21Z","timestamp":1759592781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383519305774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":48,"alternative-id":["S0304383519305774"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2019.11.022","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Somatic gene mutation signatures predict cancer type and prognosis in multiple cancers with pan-cancer 1000 gene panel","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2019.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}